Agglutination method for the determination of multiple ligands

• US 5,219,763 A
• Filed: 08/03/1990
• Issued: 06/15/1993
• Est. Priority Date: 11/04/1988
• Status: Expired due to Fees

• Current Assignee: Chemunex
• Original Assignee: Chemunex
• Inventors: Van Hoegaerden, Michel
• Primary Examiner(s): Kepplinger, Esther L.
• Assistant Examiner(s): Chin, Christopher L.
• Application Number:
  US07/499,509
• Time in Patent Office: 1,047 Days
• Field of Search: 422/82.01, 422/82.08, 436/523, 436/524, 436/527-531, 436/533, 436/534, 436/538, 436/536, 436/800, 436/805, 435/973
• US Class Current: 436/523
• CPC Class Codes: G01N 33/582 with fluorescent label
• CPC Class Codes: G01N 33/585 with a particulate label, e.g. coloured latex
• CPC Class Codes: Y10S 435/973 Simultaneous determination of more than one analyte
• CPC Class Codes: Y10S 436/80 Fluorescent dyes, e.g. rhodamine
• CPC Class Codes: Y10S 436/805 Optical property

Abstract

The invention provides a method capable of determining the presence or absence of each of a plurality of different ligands in a specimen. The specimen is contacted with a predetermined number of different homogenous populations of fluorescent beads having one or more predetermined antiligands affixed to their surface. The specimen and bead mixture is analyzed using a means having a single parameter of measuring fluorescence per ligand to determine the number of non-agglutinated beads, the number of agglutinated beads, the number of bead aggregates, and for each aggregate, the number of beads its comprises. This information is used to correlate the presence or absence in the specimen of each of the different ligands analyzed for. The method of the invention thus provides for the simultaneous determination of a predetermined number of ligands in a specimen using only a single bead contacting step.

Claims

1. A method for determining the presence or absence of each of a predetermined number of three or more ligands in a liquid, semi-liquid or pasty specimen, by a direct or indirect aggultination, or an aggultination inhibition method by competition, comprising the steps:

contacting the specimen with a predetermined number of homogenous populations of fluorescent beads having a specific fluorescence and one or more pre-determined antiligands fixed to their surface, said predetermined number of populations being less than said predetermined number of ligands and wherein at least one of said ligands is capable of binding to the antiligand on two or more of said homogeneous populations of beads;

analyzing said specimen containing said beads using a measuring means capable of discriminating between the specific fluorescence of said beads for each ligand;

determining in response to said analyzing step the number of non-agglutinated beads, the number of agglutinated beads, the number of bead aggregates and for each aggregate, the number of the beads it comprises; and

correlating the information determined in said determining step with the presence or absence in said specimen, of each of said different ligands to thereby enable the simultaneous determination of a plurality of ligands using a single bead contacting step.

2. The method according to claim 1, wherein said beads comprise at least two predetermined antiligands fixed to their surface.

3. The method according to claim 1, wherein said beads have a diameter of between 0.05 μ

m and 10 μ

m.

4. The method according to claim 1, wherein said antiligand is selected from the group consisting of antigens, antibodies, receptors, lectins, proteins of type A or G, and avidin, said antiligand being specific to one or more of said predetermined number of different ligands.

5. The method according to claim 4, wherein the antibodies are monoclonal antibodies.

6. The method according to claim 4, wherein the antibodies are polyclonal antibodies.

7. The method according to claim 1, wherein said measuring means used in said analyzing step is selected from the group consisting of a flow cytometer, an image analyzer and a laser sweep system.

8. The method according to claim 1 wherein said correlating step is conducted in a manner to determine quantitative values for each of said ligands.

9. A method for determining the presence or absence of each of a predetermined number of a plurality of different ligands in a liquid, semi-liquid or pasty specimen, by a direct or indirect agglutination, or an agglutination inhibition method by competition, comprising the steps:

contacting the specimen with a predetermined plurality of homogenous populations of fluorescent beads having a specific fluorescence and one or more predetermined antiligands fixed to their surface, said predetermined plurality of populations being less than said predetermined number of ligands and wherein at least one of said ligands is capable of binding to the antiligand on two or more of said homogeneous populations of beads;

when said predetermined number of ligands;

analyzing said specimen containing said beads using a measuring means capable of discriminating between the specific fluorescence of said beads for each ligand;

determining in response to said analyzing step, the number of non-agglutinated beads, the number of agglutinated beads, the number of bead aggregates and for each aggregate, the number of beads it comprises and the population type or types of beads it comprises; and

correlating the information determined in said determining step with the presence or absence in said specimen of each of said different ligands to thereby enable the simultaneous determination of a plurality of ligands using a single bead contacting step.

10. The method according to claim 9 wherein the beads in at least one of said homogenous populations of beads comprise at least two antiligands affixed to their surface.

11. The method according to claim 9 wherein said beads have a diameter of between 0.05 μ

m and 10 μ

m.

12. The method according to claim 9 wherein the antiligands fixed to the surface of said beads are specific to one or more of said predetermined plurality of different ligands and are selected from the group consisting of antigens, antibodies, receptors, lectins, proteins of type A or G, or avidin.

13. The method according to claim 12 wherein the antibodies are monoclonal antibodies.

14. The method according to claim 12 wherein the antibodies are polyclonal antibodies.

15. The method according to claim 9 wherein the measuring means used in said analyzing step is selected from the group consisting of a flow cytometer, an image analyzer and a laser sweep system.

16. The method according to claim 9 wherein said correlating step is conducted in a manner to determine quantitative values for each of said ligands.